Eunkyung Jo
Ewha Womans University · 医学
研究室紹介
Professor Eunkyung Jo's research lab specializes in hematological malignancies, with a primary focus on acute myeloid leukemia (AML). The lab investigates post-remission therapies, particularly comparing high-dose cytarabine and autologous stem cell transplantation, to optimize treatment strategies based on cytogenetic and molecular markers. Their work aims to clarify the role of intensive therapies in improving survival while minimizing treatment-related mortality. The lab also explores prognostic factors and personalized treatment approaches in AML patients.
Research Overview
Research Output Trend
Figures are computed from collected data and may differ slightly.
Selected Papers
2Abstract Cytogenetics is still being considered the most powerful single prognostic factor, which is useful to determine the types of post-remission therapy in AML, though various molecular markers are available for predicting the prognosis of AML patients. Most phase III studies have failed to demonstrate a clear advantage of allografting over chemotherapy in terms of overall survival because of significant risk of transplant-related mortality. Optimal post-remission therapies in terms of frequ